Skip to content

Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions

Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions: A Randomized, Double-blind Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04642001
Enrollment
24
Registered
2020-11-24
Start date
2019-08-07
Completion date
2020-11-05
Last updated
2020-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Hypersensitivity

Brief summary

This randomized, double-blind clinical trial evaluated the effect of photobimodulation associated with 8% strontium acetate in the treatment of dentin hypersensitivity in non-carious lesions and analyzed the risk factors with the patient's quality of life.

Interventions

OTHERPhoton Laser III-DMC (without radiation emission) + My First- Colgate

Positioning of the FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

OTHERPhoton Laser III-DMC (without radiation emission) + Sensodyne® Rapid Relief / GSK

Positioning of FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

RADIATIONPhoton Laser III-DMC (with irradiation emission) + My First- Colgate

Emission of FBM therapy (Photon Laser III / DMC), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

COMBINATION_PRODUCTPhoton Laser III-DMC (with irradiation emission) +Sensodyne® Rapid Relief / GSK

Emission of FBM therapy (Photon Laser III / DMC), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Sponsors

Universidade Federal do Para
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 to 50 years * Good general health * Dental sensitivity with response ≥ 4 on the 10 cm long visual analog scale (EVA) * Presence of at least two hypersensitive teeth with a depth of up to 1 mm (measured with a millimeter probe) * Exposed root surface caused by abrasion, erosion or gum recession

Exclusion criteria

* Volunteers using analgesic medication * Presence of teeth with evidence of carious lesions, pulpitis, defective restorations and moderate or severe periodontal disease * Patients who had undergone any whitening therapy or professional or homemade desensitizer in the last six months * Patient with fixed orthodontic appliances * Drug users or pregnant women were also excluded.

Design outcomes

Primary

MeasureTime frameDescription
dentin sensitivity30 days after the end of treatmentevaluation of dentinal sensitivity during treatment and one month after its end, by means of tactile and evaporative stimuli according to the visual analog scale with values from 0 to 10, with higher values indicating a worse level of pain.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026